| Sweet berberine C Wang, SR Perumalla, R Lu, J Fang, CC Sun Crystal Growth & Design 16 (2), 933-939, 2016 | 68 | 2016 |
| Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulator R Lu, C Groer, PA Kleindl, KR Moulder, A Huang, JR Hunt, S Cai, ... Journal of Controlled Release 306, 165-176, 2019 | 62 | 2019 |
| Human intratumoral therapy: Linking drug properties and tumor transport of drugs in clinical trials A Huang, MM Pressnall, R Lu, SG Huayamares, JD Griffin, C Groer, ... Journal of Controlled Release 326, 203-221, 2020 | 39 | 2020 |
| Intratumoral cancer chemotherapy with a carrier-based immunogenic cell-death eliciting platinum (IV) Agent C Groer, T Zhang, R Lu, S Cai, D Mull, A Huang, M Forrest, C Berkland, ... Molecular pharmaceutics 17 (11), 4334-4345, 2020 | 19 | 2020 |
| Glatiramer Acetate Complexed with CpG as Intratumoral Immunotherapy in Combination with Anti-PD-1 A Huang, C Groer, R Lu, ML Forrest, JD Griffin, CJ Berkland Molecular Pharmaceutics 19 (11), 4357-4369, 2022 | 2 | 2022 |
| Platinum (IV) conjugates and methods of use L Forrest, D Aires, R Moulder, R Lu, J Hunt, P Kleindl, T Zhang, C Groer, ... US Patent 11,458,163, 2022 | | 2022 |
| Imidazoquinoline compounds and prodrugs thereof L Forrest, D Aires, R Moulder, R Lu, J Hunt, P Kleindl, T Zhang, C Groer, ... US Patent App. 17/598,160, 2022 | | 2022 |
| Design and Delivery of TLR7/8 Agonists for Immunotherapy R Lu University of Kansas, 2021 | | 2021 |
M. Laird ForrestUniversity of Kansas在 ku.edu 的电子邮件经过验证
